Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-163140
Filing Date
2014-04-28
Accepted
2014-04-28 16:41:42
Documents
4
Period of Report
2014-05-28
Effectiveness Date
2014-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d652806ddef14a.htm DEF 14A 1041193
2 GRAPHIC g652806g15g84.jpg GRAPHIC 146494
3 GRAPHIC g652806g85m25.jpg GRAPHIC 58339
4 GRAPHIC g652806g86a44.jpg GRAPHIC 178210
  Complete submission text file 0001193125-14-163140.txt   1570448
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 14789973
SIC: 2834 Pharmaceutical Preparations